Treatment advances in early-stage primary systemic anaplastic large cell lymphoma / 肿瘤研究与临床
Cancer Research and Clinic
;
(6): 493-497, 2016.
Artículo
en Chino
| WPRIM
| ID: wpr-495470
ABSTRACT
Primary systemic anaplastic large cell lymphoma (ALCL) is a subtype of rare and heterogeneous clinical entity, extremely rare in early stage of disease. There is no standard treatment yet. Based on retrospective studies, systematic chemotherapy followed by involved field radiation after chemotherapy is the mainstay of treatment. The role of radiotherapy in the treatment of early stage ALCL remains unclear due to lack of prospective studies. So do the optimal chemotherapy regimens and hematopoietic stem cell transplantation. The paper will review these issues.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Tipo de estudio:
Estudio observacional
Idioma:
Chino
Revista:
Cancer Research and Clinic
Año:
2016
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS